Healthcare provider profile · identity verified

Sarah Beth Low, MD

Family Practice · TYLER, TX · NPI 1720308745

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	363	116
Levothyroxine Sodium	Levothyroxine Sodium	302	84
Amlodipine Besylate	Amlodipine Besylate	254	74
Gabapentin	Gabapentin	250	78
Pantoprazole Sodium	Pantoprazole Sodium	235	75
Rosuvastatin Calcium	Rosuvastatin Calcium	207	64
Lisinopril	Lisinopril	197	61
Montelukast Sodium	Montelukast Sodium	147	41
Omeprazole	Omeprazole	142	44
Losartan Potassium	Losartan Potassium	140	40
Metoprolol Succinate	Metoprolol Succinate	137	43
Potassium Chloride	Potassium Chloride	134	50
Metformin Hcl	Metformin Hcl	112	30
Albuterol Sulfate Hfa	Albuterol Sulfate	111	32
Trazodone Hcl	Trazodone Hcl	101	33
Hydrochlorothiazide	Hydrochlorothiazide	99	34
Duloxetine Hcl	Duloxetine Hcl	98	31
Buspirone Hcl	Buspirone Hcl	88	31
Furosemide	Furosemide	88	32
Sertraline Hcl	Sertraline Hcl	88	30
Ozempic	Semaglutide	87	14
Tramadol Hcl	Tramadol Hcl	87	14
Simvastatin	Simvastatin	83	23
Bupropion Xl	Bupropion Hcl	80	25
Meloxicam	Meloxicam	79	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	25
Pravastatin Sodium	Pravastatin Sodium	72	22
Metformin Hcl Er	Metformin Hcl	71	24
Pregabalin	Pregabalin	68	18
Fluoxetine Hcl	Fluoxetine Hcl	66	16
Venlafaxine Hcl Er	Venlafaxine Hcl	62	15
Fluticasone Propionate	Fluticasone Propionate	61	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	20
Januvia	Sitagliptin Phosphate	57	14
Alendronate Sodium	Alendronate Sodium	54	15
Atenolol	Atenolol	54	17
Tizanidine Hcl	Tizanidine Hcl	54	21
Clopidogrel	Clopidogrel Bisulfate	53	21
Metoprolol Tartrate	Metoprolol Tartrate	53	17
Ondansetron Odt	Ondansetron	51	17
Allopurinol	Allopurinol	50	17
Mounjaro	Tirzepatide	50	11
Celecoxib	Celecoxib	49	15
Zolpidem Tartrate	Zolpidem Tartrate	48	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	13
Memantine Hcl	Memantine Hcl	45	12
Methocarbamol	Methocarbamol	45	15
Carvedilol	Carvedilol	44	16
Eliquis	Apixaban	41	14
Alprazolam	Alprazolam	40	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Famotidine	Famotidine	39	14
Mirtazapine	Mirtazapine	39	12
Citalopram Hbr	Citalopram Hydrobromide	38	14
Tamsulosin Hcl	Tamsulosin Hcl	38	15
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Estradiol	Estradiol	37	17
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Symbicort	Budesonide/Formoterol Fumarate	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	34	13
Diclofenac Sodium	Diclofenac Sodium	34	13
Synthroid	Levothyroxine Sodium	33	14
Olmesartan Medoxomil	Olmesartan Medoxomil	32	11
Temazepam	Temazepam	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	11
Amitriptyline Hcl	Amitriptyline Hcl	28	12
Doxepin Hcl	Doxepin Hcl	24	suppressed
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	16
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Cephalexin	Cephalexin	23	20
Ibuprofen	Ibuprofen	23	suppressed
Topiramate	Topiramate	23	suppressed
Spironolactone	Spironolactone	22	11
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Prednisone	Prednisone	21	19
Baclofen	Baclofen	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Fluconazole	Fluconazole	19	14
Lorazepam	Lorazepam	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	16
Finasteride	Finasteride	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Primidone	Primidone	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Valsartan	Valsartan	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Glipizide	Glipizide	13	suppressed
Ibu	Ibuprofen	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Nystatin	Nystatin	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Linzess	Linaclotide	12	suppressed
Naproxen	Naproxen	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Azithromycin	Azithromycin	11	11
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error